AJHM Issues - 2019
American Journal of Homeopathic Medicine - 2018
Welcome to the AJHM. Below are a list of the issues for 2019. To preview prior years, click on the menu to the right.
If you are an AIH Member or Digital Subscriber, please sign-in to enjoy full access to all the AJHM Journal Content.
AJHM - 2019
Latest Issue of the AJHM
Spring - 2019 e-issue
Volume 112 Number 1
Table of Contents
Something on Moschus - a pure pharmacography1
George Dimitriadis, BSc.(UNSW), DHom.(Syd), DHomMCCH(Eng), M(Hon)JPHMA (Jpn), LiRF(HISyd)
Hahnemann Institute Sydney
Abstract:Moschus moschiferus was originally proved by Hahnemann and its pathogenesis is explored in reference to original proving sources. Formative substance trials (provings) reveal spasmodic, “hysterical”, convulsive and ataxic effects with characteristic concomitants and specific organ affinity. A case that was finally cured by this remedy is presented in detail with case analysis and case management discussion. Discussion also includes non-homoeopathic old-school sources which further elucidate the pathogenesis. Hahnemann’s pharmacographies are unmatched in their accuracy of recording and reporting the consistent effects (characteristics) of substances, with remarkable fidelity to the original sources cited.
Keywords: Moschus moschiferus, pharmacogenesis, primary source materia medica, case of “tantrums”, ammoniacal odour of urine, impotency.
Large Scale Homoeoprophylaxis: Results of Brief and Long-Term Interventions - Isaac Golden, PhD
Research Consultant, National Institute of Integrative Medicine, Melbourne, Australia.
Introduction: The term homoeoprophylaxis (HP) was first coined by Burnett in 1884 to refer to medicines selected according to the Law/Principle of Similars to prevent targeted infectious diseases. HP medicines were first used by Hahnemann in 1798 and have been used since to protect significant numbers of people against a range of infectious diseases in many countries. This paper updates a recent analysis of HP use internationally, and examines a large intervention conducted over 11 years.
Aims: To present a brief “snapshot” of some major HP interventions in three countries and to illustrate to those who are unfamiliar with HP the extent to which it has been and is being used, often by Government-employed medical officers and scientists, in many countries. To use new data to analyze the value of HP against established diseases.
Methods: Using a previous analysis as a starting point, a literature search for new data concerning